https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-horizant-22399-gabapentin-enacarbil-for-extended-release-tablets-300-mg-and-600-mg-1560927506.pdf
01 Oct 2015
// Rosmi Shaji REUTERS
http://www.reuters.com/article/2015/10/01/us-xenoport-ceo-idUSKCN0RV5V920151001
LOOKING FOR A SUPPLIER?